196 related articles for article (PubMed ID: 12067677)
21. Opioid-Induced Constipation Part 2: Newer Therapies #295.
Badke A; Rosielle DA
J Palliat Med; 2015 Oct; 18(10):893-4. PubMed ID: 26439728
[No Abstract] [Full Text] [Related]
22. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
Yuan CS
J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
[TBL] [Abstract][Full Text] [Related]
23. Opioid side effects--mechanism-based therapy.
Berde C; Nurko S
N Engl J Med; 2008 May; 358(22):2400-2. PubMed ID: 18509126
[No Abstract] [Full Text] [Related]
24. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
Mehta N; O'Connell K; Giambrone GP; Baqai A; Diwan S
Postgrad Med; 2016; 128(3):282-9. PubMed ID: 26839023
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic treatment of opioid-induced constipation.
Wang CZ; Yuan CS
Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
[TBL] [Abstract][Full Text] [Related]
26. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
27. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
Lee JM; Mooney J
Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
Mori M; Ji Y; Kumar S; Ashikaga T; Ades S
Int J Clin Oncol; 2017 Apr; 22(2):397-404. PubMed ID: 27628064
[TBL] [Abstract][Full Text] [Related]
29. Management of constipation in patients receiving palliative care.
Cayley WE
Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655
[No Abstract] [Full Text] [Related]
30. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.
Shaiova L; Rim F; Friedman D; Jahdi M
Palliat Support Care; 2007 Jun; 5(2):161-6. PubMed ID: 17578067
[TBL] [Abstract][Full Text] [Related]
31. Naldemedine effective in treating opioid-induced constipation.
Brower V
Lancet Oncol; 2017 Jun; 18(6):e306. PubMed ID: 28483411
[No Abstract] [Full Text] [Related]
32. An overview of constipation and newer therapies.
Enck RE
Am J Hosp Palliat Care; 2009; 26(3):157-8. PubMed ID: 19531698
[No Abstract] [Full Text] [Related]
33. Methylnaltrexone for opioid-induced constipation in advanced illness.
Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
[TBL] [Abstract][Full Text] [Related]
34. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
[TBL] [Abstract][Full Text] [Related]
35. Paediatric palliative care: intravenous methylnaltrexone relieves constipation.
Yeomanson D; Chohan O; Mayer A
BMJ Support Palliat Care; 2013 Mar; 3(1):103-5. PubMed ID: 24644335
[TBL] [Abstract][Full Text] [Related]
36. Methylnaltrexone: MNTX.
Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
[TBL] [Abstract][Full Text] [Related]
37. [Methylnaltrexone. A new approach for therapy of opioid-induced obstipation].
Chappell D; Conzen P
Schmerz; 2009 Oct; 23(5):471-8. PubMed ID: 19690895
[TBL] [Abstract][Full Text] [Related]
38. Methylnaltrexone for opioid-induced constipation in patients at the end of life.
Santucci G; Battista V
Int J Palliat Nurs; 2015 Apr; 21(4):162, 164. PubMed ID: 25901587
[No Abstract] [Full Text] [Related]
39. Current concepts in the management of opioid-induced constipation: a perfect review with an imperfect concept.
Ruan X
J Opioid Manag; 2011; 7(3):167, 170; author reply 170-2. PubMed ID: 21823547
[No Abstract] [Full Text] [Related]
40. Methylnaltrexone: the answer to opioid-induced constipation?
Cannom RR; Mason RJ
Expert Opin Pharmacother; 2009 Apr; 10(6):1039-45. PubMed ID: 19364251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
